Kean Driscoll Sells 6,875 Shares of Validus Holdings, Ltd. (VR) Stock

Validus Holdings, Ltd. (NYSE:VR) President Kean Driscoll sold 6,875 shares of Validus stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $46.78, for a total value of $321,612.50. Following the sale, the president now directly owns 103,983 shares in the company, valued at $4,864,324.74. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Kean Driscoll also recently made the following trade(s):

  • On Friday, December 15th, Kean Driscoll sold 6,875 shares of Validus stock. The shares were sold at an average price of $46.16, for a total value of $317,350.00.
  • On Wednesday, November 15th, Kean Driscoll sold 6,875 shares of Validus stock. The shares were sold at an average price of $50.30, for a total value of $345,812.50.

Shares of Validus Holdings, Ltd. (VR) traded up $0.46 on Wednesday, hitting $47.28. The stock had a trading volume of 446,655 shares, compared to its average volume of 728,156. Validus Holdings, Ltd. has a 52 week low of $41.15 and a 52 week high of $58.76. The company has a quick ratio of 0.95, a current ratio of 0.95 and a debt-to-equity ratio of 0.52. The company has a market capitalization of $3,760.00, a P/E ratio of -72.74, a price-to-earnings-growth ratio of 1.25 and a beta of 0.67.

Validus (NYSE:VR) last issued its quarterly earnings data on Thursday, October 26th. The insurance provider reported ($3.22) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($3.30) by $0.08. Validus had a negative return on equity of 0.49% and a negative net margin of 1.38%. The company had revenue of $407.00 million during the quarter, compared to the consensus estimate of $453.04 million. During the same period last year, the company earned $1.02 earnings per share. The firm’s revenue was up 24.3% compared to the same quarter last year. research analysts predict that Validus Holdings, Ltd. will post -0.3 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 29th. Stockholders of record on Friday, December 15th were given a dividend of $0.38 per share. The ex-dividend date of this dividend was Thursday, December 14th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 3.21%. Validus’s dividend payout ratio (DPR) is -233.85%.

VR has been the topic of a number of recent research reports. Keefe, Bruyette & Woods reissued a “hold” rating and set a $51.00 price target on shares of Validus in a research note on Thursday, October 12th. UBS Group lifted their price target on Validus from $48.00 to $52.00 and gave the company a “neutral” rating in a research note on Monday, October 30th. Bank of America upgraded Validus from a “neutral” rating to a “buy” rating in a research report on Monday, October 30th. ValuEngine downgraded Validus from a “buy” rating to a “hold” rating in a research report on Wednesday, October 11th. Finally, TheStreet downgraded Validus from a “b” rating to a “c+” rating in a research report on Wednesday, October 11th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and four have given a buy rating to the company. Validus presently has a consensus rating of “Hold” and a consensus target price of $54.33.

Institutional investors and hedge funds have recently modified their holdings of the company. SG Americas Securities LLC bought a new stake in Validus in the second quarter worth approximately $116,000. Zions Bancorporation bought a new stake in Validus in the third quarter worth approximately $116,000. The Manufacturers Life Insurance Company increased its holdings in Validus by 10.1% in the second quarter. The Manufacturers Life Insurance Company now owns 2,382 shares of the insurance provider’s stock worth $124,000 after purchasing an additional 219 shares in the last quarter. BNP Paribas Arbitrage SA increased its holdings in Validus by 93.7% in the second quarter. BNP Paribas Arbitrage SA now owns 2,650 shares of the insurance provider’s stock worth $138,000 after purchasing an additional 1,282 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Validus by 10.6% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,905 shares of the insurance provider’s stock worth $151,000 after purchasing an additional 278 shares in the last quarter. Institutional investors own 96.25% of the company’s stock.

WARNING: This piece of content was reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece of content on another website, it was stolen and reposted in violation of United States and international copyright & trademark laws. The correct version of this piece of content can be read at https://www.com-unik.info/2018/01/17/kean-driscoll-sells-6875-shares-of-validus-holdings-ltd-vr-stock.html.

Validus Company Profile

Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.

Insider Buying and Selling by Quarter for Validus (NYSE:VR)

Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit